Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Acetylsalicylic acid (1)
- Alcoholism (1)
- Alpha-2 adrenergic agonists (1)
- Animals (1)
- Anthelmintics (1)
-
- Antinociception (1)
- Atorvastatin (1)
- Child (1)
- Child, Preschool (1)
- Cyathostomin (1)
- Exercise-induced pulmonary hypertension (1)
- Feces (1)
- Female (1)
- Guanabenz (1)
- Histopathology (1)
- Horse Diseases (1)
- Horses (1)
- Humans (1)
- Male (1)
- MiRNA155 (1)
- Molecular docking (1)
- NLRP3 inflammasomes (1)
- Parasite Egg Count (1)
- Parasites (1)
- Preschool (1)
- Seasonality (1)
- Sedation (1)
- Serology; Strongyle (1)
- Statins (1)
- Strongylus (1)
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated With Atorvastatin Intake By Targeting Cerebral Mirna155 And Nlrp3: In Vivo, And In Silico Study, Doaa I. Mohamed, Dalia Alaa El-Din Aly El-Waseef, Enas S. Nabih, Omnyah A. El-Kharashi, Hanaa F. Abd El-Kareem, Hebatallah H. Abo Nahas, Basel A. Abdel-Wahab, Yosra A. Helmy, Samar Zuhair Alshawwa, Essa M. Saied
Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated With Atorvastatin Intake By Targeting Cerebral Mirna155 And Nlrp3: In Vivo, And In Silico Study, Doaa I. Mohamed, Dalia Alaa El-Din Aly El-Waseef, Enas S. Nabih, Omnyah A. El-Kharashi, Hanaa F. Abd El-Kareem, Hebatallah H. Abo Nahas, Basel A. Abdel-Wahab, Yosra A. Helmy, Samar Zuhair Alshawwa, Essa M. Saied
Veterinary Science Faculty Publications
Alcoholism is one of the most common diseases that can lead to the development of several chronic diseases including steatosis, and cognitive dysfunction. Statins are lipid-lowering drugs that are commonly prescribed for patients with fatty liver diseases; however, the exact effect of statins on cognitive function is still not fully understood. In the present study, we have investigated the molecular and microscopic basis of cognitive impairment induced by alcohol and/or Atorvastatin (ATOR) administration to male Wistar albino rats and explored the possible protective effect of acetylsalicylic acid (ASA). The biochemical analysis indicated that either alcohol or ATOR or together in …
Parasite Dynamics In Untreated Horses Through One Calendar Year, Ashley E. Steuer, Haley P. Anderson, Taylor Shepherd, Morgan Clark, Jessica A. Scare, Holli S. Gravatte, Martin K. Nielsen
Parasite Dynamics In Untreated Horses Through One Calendar Year, Ashley E. Steuer, Haley P. Anderson, Taylor Shepherd, Morgan Clark, Jessica A. Scare, Holli S. Gravatte, Martin K. Nielsen
Veterinary Science Faculty Publications
BACKGROUND: Horses are host to a plethora of parasites. Knowledge of the seasonality of parasite egg shedding and transmission is important for constructing parasite control programs. However, studies describing these patterns are sparse, and have largely been conducted only in the United Kingdom. This study evaluated strongylid egg shedding patterns and transmission dynamics of Strongylus vulgaris in naturally infected and untreated mares and foals through one calendar year in Kentucky, USA. The study also investigated the existence of a peri-parturient rise (PPR) in strongylid egg counts in foaling mares and collected information about Strongyloides westeri and Parascaris spp. in the …
Guanabenz In The Horse – A Preliminary Report On Clinical Effects And Comparison To Clonidine And Other Alpha-2 Adrenergic Agonists, Andreas F. Lehner, L. Dirikolu, Thomas Tobin
Guanabenz In The Horse – A Preliminary Report On Clinical Effects And Comparison To Clonidine And Other Alpha-2 Adrenergic Agonists, Andreas F. Lehner, L. Dirikolu, Thomas Tobin
Veterinary Science Faculty Publications
In veterinary medicine, a number of alpha-2 receptor agonists are marketed as sedatives/hypnotics and analgesics, with their principal use being the chemical restraint of large and small animals. Guanabenz (Wytensin®) is an alpha-2 adrenergic receptor agonist marketed for use in humans as an anti-hypertensive agent. Recent reports indicate that guanabenz has been administered to horses in small doses (0.04 mg/kg) for its anti-hypertensive effects. While this offers both benefits of sedation of the horse as well as amelioration of pulmonary hypertension during running exercise and consequent Exercise-Induced Pulmonary Hemorrhage (EIPH), guanabenz is currently proscribed in most racing jurisdictions and its …